Rahsaan Thompson Kempharm, Inc (KMPH) insider trading activity

Rahsaan Thompson is Chief Legal & Compliance of KEMPHARM, INC. Currently has a direct ownership of 42,666 shares of KMPH, which is worth approximately $210,770. The most recent transaction as insider was on Jun 26, 2025, when has been sold 24,000 shares (Common Stock) at a price of $9.21 per share, resulting in proceeds of $221,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 42.7K

n/a 3M change

n/a 12M change

Total Value Held $210,770

Rahsaan Thompson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 26 2025	SELL Open market or private sale	$221,040 $9.21 p/Share	24,000 Reduced 36.0%	42,666 Common Stock
Jun 21 2025	BUY Exercise of conversion of derivative security	-	66,666 Added 50.0%	66,666 Common Stock

Also insider at

GRTS

Gritstone bio, Inc. Healthcare

EVP and General Counsel

LYEL

Lyell Immunopharma, Inc. Healthcare

Chief Legal Officer